THE ROLE OF ARTIFICIAL INTELLIGENCE IN BIOCHEMICAL RESEARCH
Keywords:
artificial intelligence, machine learning, biochemistry, protein structure prediction, enzyme engineering, multi-omics, metabolomics, drug discoveryAbstract
Artificial intelligence (AI) has become an increasingly important tool in modern biochemical research. The rapid development of genomics, proteomics, metabolomics, structural biology, and high-throughput experimental technologies has generated large and complex datasets that are difficult to analyze using conventional approaches alone. AI-based methods, particularly machine learning and deep learning, provide new possibilities for identifying molecular patterns, predicting protein structures, analyzing enzyme properties, integrating multi-omics data, and supporting drug discovery. This review examines the current applications of AI in biochemical research and evaluates its potential advantages and limitations. The analysis shows that AI can accelerate data interpretation, assist in the prediction of molecular properties, support enzyme engineering, identify potential therapeutic targets, and improve the selection of compounds for experimental testing. At the same time, problems related to data quality, model interpretability, reproducibility, and experimental validation remain important challenges. Therefore, AI should not replace experimental biochemistry but should be integrated with laboratory approaches to improve the efficiency and precision of scientific research. The combination of artificial intelligence and experimental biochemistry may provide new opportunities for understanding complex molecular processes and developing innovative biomedical applications.
References
Bender, A., Thomas, M. C., Scannell, J. W., et al. (2026). Artificial intelligence in drug discovery — what it is, where we stand and the path forward. Nature Reviews Drug Discovery.
Chaudhari, K. A., Mathpati, K. S., & Alte, A. R. (2026). Artificial intelligence and machine learning in drug discovery and development: A comprehensive review. Future Journal of Pharmaceutical Sciences, 12, 70.
Huynh, D. L., Seal, S., & AIA4S Consortium. (2026). AI agents in drug discovery: Applications and case studies. Drug Discovery Today, 31(3), 104650.
Pun, F. W., Podolskiy, D., Izumchenko, E., et al. (2026). Target identification and assessment in the era of AI. Nature Reviews Drug Discovery, 25, 534–552.
“Artificial intelligence methods for protein structure and interaction prediction: Recent advances and challenges.” (2026). Current Opinion in Structural Biology, 98, 103247.
“Artificial intelligence tools for enzyme engineering and metabolic engineering.” (2026). Current Opinion in Biotechnology, 100, 103522.
“From machine learning to multimodal models: The AI revolution in enzyme engineering.” (2026). BioDesign Research, 8(1), 100044.
“Artificial intelligence–powered biofoundries for protein engineering and metabolic engineering.” (2025). Current Opinion in Biotechnology, 96, 103380.
“Closing the loop: Experimentally validated methods in artificial intelligence–driven protein design.” (2026). Current Opinion in Structural Biology, 98, 103272.
“AI-driven drug discovery: A comprehensive review.” (2025). ACS Omega.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in IQRO — Scientific Methodological Journal are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright and grant the journal the right of first publication.
Users may read, download, copy, distribute, print, search, or link to the full texts of articles, provided that the original authors and the journal are properly cited.
Published materials may be used, distributed, and reproduced in any medium, provided that the original work is properly cited.



Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo